Trials / Completed
CompletedNCT01015937
Effect of Turmeric on Diabetic Nephropathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Shaheed Faghihi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate whether turmeric is effective in improvement of diabetic nephropathy and in decrease in the amount of proteinuria and cytokine levels.
Detailed description
Diabetic nephropathy is leading cause of ESRF that many therapy recommended for it. In this study, we investigate effect of turmeric on diabetic nephropathy, thus we selected diabetic nephropathy patients and divided them into 2 groups. One group received turmeric + ACE inhibitor + Angiotensin II receptor blocker (ARB) and the second group received only ACE inhibitor + ARB.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Turmeric extract | turmeric 500 mg TID for 45 days |
| DRUG | Angiotensin-converting enzyme (ACE) inhibitor + Angiotensin-II type 1 receptor (ATI) blocker | maximum dosage as patient tolerated for 45 days |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2009-06-01
- Completion
- 2009-08-01
- First posted
- 2009-11-18
- Last updated
- 2009-11-18
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01015937. Inclusion in this directory is not an endorsement.